Nearly a year after the US Food and Drug Administration placed a hold on the first clinical trial of human embryonic stem cells, the company Geron has been cleared to continue its study of spinal cord injury, it announced today (July 30). Human embryonic stem cells Image: Wikimedia commons, Nissim Benvenisty “We are pleased with the FDA’s [...]
Filed under: Noticias | Tagged: Embryonic stem cell, Geron, GRNOPC1, human embryonic stem cell (hESC), Thomas Okarma | Leave a Comment »
